Santen Pharmaceutical Co Ltd (4536) - Financial and Strategic SWOT Analysis Review

Date: December 20, 2016
Pages: 51
Price:
US$ 300.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: S68ED1751EBEN
Leaflet:

Download PDF Leaflet

Santen Pharmaceutical Co Ltd (4536) - Financial and Strategic SWOT Analysis Review
Santen Pharmaceutical Co Ltd (4536) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Santen Pharmaceutical Co Ltd (Santen) is a pharmaceutical company. It focuses on the development and manufacture of pharmaceutical products and medical devices. Santen specializes in ophthalmological products. Its product portfolio includes prescription ophthalmic products, anti-rheumatics, OTC drugs, anti-allergy ophthalmic products, prescription anti-rheumatic drugs and medical devices such as intraocular lenses, among others. The company markets its products under brand names such as Livostin, Alesion, Metadate, Cravit, Diquas and Hyalein, among others. It has manufacturing plants and laboratories in France, Japan, China, Finland and the US. The company markets its products in over 50 countries. Santen is headquartered in Osaka, Japan.

Santen Pharmaceutical Co Ltd Key Recent Developments

Nov 02, 2016: Santen Consolidated Results for Q2 Fiscal 2016
Oct 03, 2016: Santen: Personnel Changes of Corporate Officer
May 11, 2016: Santen Reports Fiscal 2015 Consolidated Performance
Feb 02, 2016: Santen Pharma Reports Revenue Of JPY149.2 Billion In Q3 Fiscal 2016
Nov 04, 2015: Santen Reports Consolidated Performance For the First Half of FY2015

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

    Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

    Note: Some sections may be missing if data is unavailable for the company
  • SECTION 1 - ABOUT THE COMPANY

    Santen Pharmaceutical Co Ltd - Key Facts
    Santen Pharmaceutical Co Ltd - Key Employees
    Santen Pharmaceutical Co Ltd - Major Products and Services
    Santen Pharmaceutical Co Ltd - Pharmaceutical Pipeline Products Data
    Santen Pharmaceutical Co Ltd, Pipeline Products by Therapy Area
    Santen Pharmaceutical Co Ltd, Pipeline Products by Development Phase
    Santen Pharmaceutical Co Ltd - History
    Santen Pharmaceutical Co Ltd - Company Statement
    Santen Pharmaceutical Co Ltd - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries

    SECTION 2 – COMPANY ANALYSIS

    Santen Pharmaceutical Co Ltd - Business Description
    Santen Pharmaceutical Co Ltd - Corporate Strategy
    Santen Pharmaceutical Co Ltd - SWOT Analysis
    SWOT Analysis - Overview
    Santen Pharmaceutical Co Ltd - Strengths
    Santen Pharmaceutical Co Ltd - Weaknesses
    Santen Pharmaceutical Co Ltd - Opportunities
    Santen Pharmaceutical Co Ltd - Threats
    Santen Pharmaceutical Co Ltd - Key Competitors

    SECTION 3 – COMPANY FINANCIAL RATIOS

    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts

    SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Santen Pharmaceutical Co Ltd, Recent Deals Summary

    SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

    Nov 02, 2016: Santen Consolidated Results for Q2 Fiscal 2016
    Oct 03, 2016: Santen: Personnel Changes of Corporate Officer
    May 11, 2016: Santen Reports Fiscal 2015 Consolidated Performance
    Feb 02, 2016: Santen Pharma Reports Revenue Of JPY149.2 Billion In Q3 Fiscal 2016
    Nov 04, 2015: Santen Reports Consolidated Performance For the First Half of FY2015
    May 12, 2015: Santen Reports Consolidated Performance for the Fiscal Year Ended March 31, 2015
    May 12, 2015: Santen Announces Assignment of its Anti-Rheumatic Pharmaceuticals Business to Hyperion Pharma
    Apr 27, 2015: Santen Launches New Sante de U a , an OTC Eye Drop
    Mar 10, 2015: Santen Pharmaceutical Announces Appointment Of Corporate Officers
    Feb 25, 2015: Santen Chooses NTT Communications' Hybrid-cloud ICT Infrastructure for Global Growth

    SECTION 6 – APPENDIX

    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Santen Pharmaceutical Co Ltd, Key Facts
    Santen Pharmaceutical Co Ltd, Key Employees
    Santen Pharmaceutical Co Ltd, Major Products and Services
    Santen Pharmaceutical Co Ltd, Number of Pipeline Products by Therapy Area
    Santen Pharmaceutical Co Ltd, Number of Pipeline Products by Development Stage
    Santen Pharmaceutical Co Ltd, History
    Santen Pharmaceutical Co Ltd, Other Locations
    Santen Pharmaceutical Co Ltd, Subsidiaries
    Santen Pharmaceutical Co Ltd, Key Competitors
    Santen Pharmaceutical Co Ltd, Ratios based on current share price
    Santen Pharmaceutical Co Ltd, Annual Ratios
    Santen Pharmaceutical Co Ltd (Cont...1), Annual Ratios
    Santen Pharmaceutical Co Ltd, Interim Ratios
    Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Santen Pharmaceutical Co Ltd, Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios

    LIST OF FIGURES

    Santen Pharmaceutical Co Ltd, Pipeline Products by Therapy Area
    Santen Pharmaceutical Co Ltd, Pipeline Products by Development Phase
    Santen Pharmaceutical Co Ltd, Performance Chart (2012 - 2016)
    Santen Pharmaceutical Co Ltd, Ratio Charts
    Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
    Skip to top


    Ask Your Question

    Santen Pharmaceutical Co Ltd (4536) - Financial and Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: